Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.60p
   
  • Change Today:
      0.100p
  • 52 Week High: 64.60
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 1,165,679
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Financial Analysis

Select chart: EPS | Dividend | Revenue

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 (23.05) 4.28p 12.4 n/a -33% 1.78p 3.4%
31-Dec-23 180.68 (48.80) 4.54p 8.9 1.5 +6% n/a 0.0%
31-Dec-24 178.84 (14.46) 4.32p 10.6 n/a -5% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 200.75 41.16 4.99p 13.0 0.8 +15% n/a 0.0%
31-Dec-26 210.82 44.50 5.59p 11.6 1.0 +12% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 17.14 8.92 13.21 1.13

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.100p
% Change 0.16 %
52 Week High 64.60
52 Week Low 29.35
Volume 1,165,679
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.31% above the market average23.31% above the market average23.31% above the market average23.31% above the market average23.31% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average76.92% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average
Income Not Available
Growth
50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average50.08% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 02-May-2025

Time Volume / Share Price
16:30 14 @ 64.50p
16:30 13 @ 64.50p
16:35 104,626 @ 64.60p
16:35 249 @ 64.60p
16:35 279 @ 64.60p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page